ABVC BIOPHARMA, INC. - Common Stock, par value $0.001 per share (ABVC)

Historical Holders from Q3 2023 to Q3 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
ABVC on Nasdaq
Shares outstanding
753,787
Price per share
$3.04
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
785,330
Holdings value
$2,387,168
% of all portfolios
0%
Share change
+417,953
Value change
+$1,270,658
Average buys %
+0%
Average sells %
-0%
Number of holders
14
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ABVC BIOPHARMA, INC. - Common Stock, par value $0.001 per share (ABVC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Lind Global Fund II LP 3.2% -67% $1,716,000 -$2,365,000 557,143 -58% Lind Global Fund II LP 30 Jun 2025
Jiang Eugene 18% $178,376 131,159 Eugene Jiang 10 Jul 2025
As of 30 Sep 2025, ABVC BIOPHARMA, INC. - Common Stock, par value $0.001 per share (ABVC) has 14 institutional shareholders filing 13F forms. They hold 785,330 shares .

Top 15 institutional shareholders own 104% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 35% 267,450 +140% 0% $813,048
GEODE CAPITAL MANAGEMENT, LLC 25% 187,812 +70% 0% $571,081
RENAISSANCE TECHNOLOGIES LLC 15% 110,500 +165% 0% $335,920
STATE STREET CORP 9.7% 72,800 +464% 0% $221,312
BlackRock, Inc. 7.5% 56,442 0% $171,584
NORTHERN TRUST CORP 3.3% 24,821 -33% 0% $75,456
XTX Topco Ltd 3.3% 24,801 -53% 0% $75,395
MILLENNIUM MANAGEMENT LLC 2.6% 19,603 0% $59,593
CITADEL ADVISORS LLC 2.1% 15,664 0% $47,619
Tower Research Capital LLC (TRC) 0.29% 2,155 +509% 0% $6,551
UBS Group AG 0.25% 1,849 0% $5,621
SIMPLEX TRADING, LLC 0.15% 1,108 0% $3,000
BANK OF AMERICA CORP /DE/ 0.02% 175 +32% 0% $532
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 0.02% 150 0% $456
SBI Securities Co., Ltd. 0% 0 -100% $0

Institutional Holders of ABVC BIOPHARMA, INC. - Common Stock, par value $0.001 per share (ABVC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 785,330 $2,387,168 +$1,270,658 $3.04 14
2025 Q2 367,377 $817,414 +$224,883 $2.22 9
2025 Q1 287,497 $304,746 -$34,327 $1.06 10
2024 Q4 409,227 $241,042 +$106,078 $0.5900 13
2024 Q3 228,092 $155,858 +$3,065 $0.6834 9
2024 Q2 220,365 $170,561 -$121,323 $0.7740 10
2024 Q1 254,432 $332,632 +$196,999 $1.31 7
2023 Q4 110,683 $128,503 +$41,980 $1.16 7
2023 Q3 76,762 $79,757 +$79,757 $1.04 8